Bacterial infections in cirrhosis:: Epidemiological changes with invasive procedures and norfloxacin prophylaxis

被引:675
作者
Fernández, J
Navasa, M
Gómez, J
Colmenero, J
Vila, J
Arroyo, V
Rodés, J
机构
[1] Univ Barcelona, Hosp Clin, IMD, Liver Unit, E-08036 Barcelona, Spain
[2] Univ Barcelona, Hosp Clin, Dept Microbiol, Barcelona, Spain
[3] Univ Barcelona, Hosp Clin, IDIBAPS, Barcelona, Spain
关键词
D O I
10.1053/jhep.2002.30082
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The extensive use of invasive procedures and of long-term norfloxacin prophylaxis in the management of cirrhotic patients may have influenced the epidemiology of bacterial infections in cirrhosis. We conducted a prospective evaluation of all bacterial infections diagnosed in patients with cirrhosis in a Liver Unit between April 1998 and April 2000. A total of 405 patients presented 572 bacterial infections in 507 admissions. Spontaneous bacterial peritonitis was the most frequent infection (138 cases). Gram-positive cocci were responsible for 53% of total bacterial infections in the study, being the main bacteria isolated in nosocomial infections (59%). Patients requiring treatment in an intensive care unit and those submitted to invasive procedures presented a higher rate of infections caused by grampositive cocci (77% vs. 48%, P < .001 and 58% vs. 40%, P < .02, respectively). Fifty percent of culture-positive spontaneous bacterial peritonitis in patients on long-term norfloxacin administration (n = 93) and 16% in patients not receiving this therapy (n = 414) were caused by quinolone-resistant gram-negative bacilli, P = .01. The rate of culture-positive spontaneous bacterial peritonitis caused by trimethoprim-sulfamethoxazole-resistant gramnegative bacilli was also very high in patients on long-term norfloxacin administration (44% vs. 18%, P = .09). In conclusion, infections caused by gram-positive cocci have markedly increased in cirrhosis. This phenomenon may be related to the current high degree of instrumentation of cirrhotic patients. Quinolone-resistant spontaneous bacterial peritonitis constitutes an emergent problem in patients on long-term norfloxacin prophylaxis, with trimethoprim-sulfamethoxazole not being a valid alternative.
引用
收藏
页码:140 / 148
页数:9
相关论文
共 48 条
[1]  
Andreu Garcia M, 1985, Med Clin (Barc), V84, P433
[2]  
[Anonymous], PRACTICAL APPROACH I
[3]   Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis:: clinical consequences [J].
Aparicio, JR ;
Such, J ;
Pascual, S ;
Arroyo, A ;
Plazas, J ;
Girona, E ;
Gutiérrez, A ;
de Vera, F ;
Palazón, JM ;
Carnicer, F ;
Pérez-Mateo, M .
JOURNAL OF HEPATOLOGY, 1999, 31 (02) :277-283
[4]   Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with ascites: A meta-analysis [J].
Bernard, B ;
Grange, JD ;
Khac, EN ;
Amiot, X ;
Opolon, P ;
Poynard, T .
DIGESTION, 1998, 59 :54-57
[5]   A PROSPECTIVE-STUDY OF BACTERIAL-INFECTIONS IN PATIENTS WITH CIRRHOSIS [J].
CALY, WR ;
STRAUSS, E .
JOURNAL OF HEPATOLOGY, 1993, 18 (03) :353-358
[6]   Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: Effect of long-term administration of norfloxacin [J].
Campillo, B ;
Dupeyron, C ;
Richardet, JP ;
Mangeney, N ;
Leluan, G .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (05) :1066-1070
[7]   SPONTANEOUS BACTERIAL PERITONITIS AND EMPYEMA BY ESCHERICHIA-COLI RESISTANT TO NORFLOXACINE IN A PATIENT ON SELECTIVE INTESTINAL DECONTAMINATION WITH NORFLOXACINE [J].
CASTELLOTE, J ;
XIOL, J ;
ROCA, RR ;
ESPARRACH, GF .
JOURNAL OF HEPATOLOGY, 1994, 20 (03) :436-436
[8]   TRANSARTERIAL EMBOLIZATION FOR HEPATOCELLULAR-CARCINOMA - ANTIBIOTIC-PROPHYLAXIS AND CLINICAL MEANING OF POSTEMBOLIZATION FEVER [J].
CASTELLS, A ;
BRUIX, J ;
AYUSO, C ;
BRU, C ;
MONTANYA, X ;
BOIX, L ;
RODES, J .
JOURNAL OF HEPATOLOGY, 1995, 22 (04) :410-415
[9]  
CLEMENTE G, 1986, GASTROENTEROL HEPAT0, V9, P285
[10]  
CURIEL MD, 1984, REV CLIN ESP, V172, P241